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Abstract 
 
 
Many descriptions of health used in vignettes and condition-specific measures refer 
to the medical condition. This paper assesses the impact of referring to the medical 
condition in the descriptions of health states valued by members of the general 
population. A sample of 241 members of the UK general population each valued 8 
health states using time trade-off. All respondents valued essentially the same health 
states, but for each respondent the descriptions featured either an irritable bowel 
syndrome label, a cancer label or no label. Regression techniques were used to 
estimate the impact of each label and experience of the condition on health state 
values. We find that the inclusion of a cancer label in health state descriptions affects 
health state values and that the impact is dependent upon the severity of the state. A 
condition label can affect health state values, but this is dependent upon the specific 
condition and severity. It is recommended to avoid condition labels in health state 
descriptions (where possible) to ensure that values are not affected by prior 
knowledge or preconception of the condition that may distort the health state being 
valued. 
 
* * * * * 
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Introduction 
 
During the past decade resource allocation across competing health care 
interventions has been increasingly informed by economic evaluation using cost- 
utility analysis. Cost-utility analysis measures the benefits of competing health care 
interventions using Quality Adjusted Life Years (QALYs) which capture both changes 
in quality and quantity of life. Typically the ‘Q’ quality adjustment weight used to 
produce the QALY estimate is obtained using an off-the-shelf generic preference- 
based measure of health such as the EQ-5D (1), which is the most commonly used 
measure and is recommended by the National Institute of Health and Clinical 
Excellence (NICE) in England and Wales (2). Whilst the EQ-5D is found to be reliable, 
valid and responsive for many conditions, such as rheumatoid arthritis (3), for other 
conditions this is not the case, such as visual impairment (4) and hearing loss (5). For 
this reason condition-specific measures (CSM) are included in many clinical trials, 
either alongside or instead of generic preference-based measures. Condition- specific 
measures will continue to be an important potential source of evidence that can be 
used to populate cost-effectiveness models for economic evaluation. However the use 
of condition-specific measures in economic evaluation is currently limited because 
most condition-specific measures are not ‘preference-based’ and thus cannot be used 
to derive the ‘quality adjustment weight’ used to estimate QALYs. 
 
Several techniques are currently used to obtain estimates of the quality adjustment 
weight for use in QALYs from existing condition-specific measures: mapping from a 
condition-specific non-preference based measure to a generic preference-based 
measure; deriving vignettes and valuing these; deriving a condition-specific 
preference-based measure from the existing non-preference-based measure. 
Mapping has gained increasing popularity in recent years for use in cost- 
effectiveness analysis as it enables a utility estimate to be produced even when a 
preference-based measure was not used in the trial. Mapping relies upon a large 
degree of overlap between both measures, yet this is not always the case for 
condition-specific and generic measures. A recent review of mapping studies found 
that some studies had large errors in predicted utility values, and that this was more 
pronounced when mapping a condition-specific measure onto a generic measure 
(6). Arguably the advantages that condition-specific measures bring through their 
focus, depth, relevance and sensitivity are lost through mapping to a generic 
measure. Furthermore, if a generic measure is inappropriate for a condition or 
population, mapping to a generic measure will also be inappropriate. 
 
Another approach commonly used to populate economic models is to develop 
vignettes or scenarios describing various health states (for example (7;8)). These can 
be based on standardised measures or more commonly are ‘bespoke’ descriptions 
that are developed specific to the condition and/or treatments being considered. 
The use of vignettes requires common health states for the trial to be developed and 
valued, meaning they are resource-intensive and usually trial-specific. This reduces 
comparability between different trials or interventions when these values are used in 
economic evaluation. Furthermore, vignettes tend to be developed from expert 
opinion rather than directly from evidence. Nonetheless this approach continues to 
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be used in the absence of better data or where a generic measure is regarded as 
inappropriate. 
 
Preference-based measures have been derived from existing condition-specific 
measures for a wide variety of conditions, including asthma (9;10) and overactive 
bladder (11;12). Contrary to vignettes, these have the advantage that they can be used 
in all trials that include the condition-specific measure, thus enabling comparability 
within a condition or patient population. A further advantage is that they retain the 
focus, depth, relevance and sensitivity of the original measure. 
 
One fundamental concern with condition-specific measures is their lack of 
comparability and applicability across different conditions or patient groups for use 
in economic evaluation (13). Typically condition-specific measures are used as a 
supplement rather than the preferred alternative to generic measures for use in 
economic evaluation. Recent NICE guidance for economic evaluation (2) states that 
condition-specific measures may be used when EQ-5D data is either inappropriate or 
unavailable (although in the latter case mapping is preferred). Comparability with 
EQ-5D can be maintained by using the same valuation ‘protocol’ including the valuation 
technique (and variant), procedures, common anchors (full health and dead), visual 
aids and the same type of respondents (such as a representative sample of the 
general population). An important difference between generic and condition- specific 
measures is the general inability of condition-specific measures to capture many co-
morbidities and side-effects, although this is specific to the measure, condition, 
treatment and patient population. The impact of excluding key dimensions is assessed 
elsewhere (14). 
 
Another important difference between generic and condition-specific measures is 
that many condition-specific preference-based measures state the cause of the 
health problems being assessed in the classification system. Non-preference-based 
condition-specific measures typically name the condition to enable greater precision 
for assessing changes in quality of life due to that condition and the relevant 
intervention, which has a significant advantage, for example, for use in drug labelling 
claims. Often the condition is embedded within the classification system derived from 
the non-preference-based measure, meaning the system cannot be valued without 
labelling the condition. For example, for an asthma-specific measure (9;10) it is 
infeasible to remove the mention of asthma without changing the meaning of the 
dimension ‘experience asthma symptoms as a result of air pollution’. Yet the 
inclusion of a condition label in a health state valuation exercise may impact on the 
values provided by members of the general population due to prior knowledge or 
preconception of the condition. This is problematic as it may mean that the elicited 
values do not reflect the health state being valued. 
 
There is disagreement in the literature regarding the extent to which naming the 
condition in health state descriptions has an impact on health state values. Some 
studies have found that the inclusion of condition labels has lowered health state 
values (15-19). For example, one study found that the explicit use of mental health 
labels including mental handicap, schizophrenia and dementia was associated with 
lower health state values (17). Two studies found that labelling breast cancer states 
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did not affect values (15;17) with the exception of scenarios written in the third 
person (15), whereas another study found that it reduced values (18). The finding 
that cancer labels have no impact is surprising given that the large majority of 
members of the general population will have prior knowledge and preconceptions of 
cancer: cancer treatments can have severe treatment side effects associated with 
low quality of life and cancer is widely known as one of the world’s largest killers, 
especially in developed countries. 
 
The majority of studies examining the impact of labelling include more than one 
condition label and find that the results differ according to the specific condition. 
Typically the studies have a small sample size (for example (18) has 26 respondents 
and (17) has 42 respondents) meaning that it is difficult to test statistical significance, 
and ask respondents to value states using a large number of different condition 
labels (for example in (18) one group value states across 9 conditions and the other 
control group value states with no condition label). All studies ask respondents to 
value states with changing descriptions (due to framing or labelling) and assess 
whether values change accordingly. This study design means that there may be a 
focussing effect, as respondents will realise that the health states are different in 
part due to the presence of the (changing) condition label (or framing). This may 
actually cause respondents to change their values accordingly, and to purposefully 
consider their prior knowledge and preconceptions of the condition. Furthermore 
the health states presented do not cover a wide range of severity meaning that the 
results are specific to the small number of states presented. To address these 
limitations we have undertaken a study to compare values from samples of 
respondents who value states with only one or no condition label across a range of 
health states of differing severity. 
 
This paper assesses the impact of referring to the medical condition in the 
descriptions of health states valued by members of the general population. We 
compare health state values that were elicited using three different labels: no label; 
irritable bowel syndrome label; cancer label. Each respondent values the same set of 
states using only one label. We further analyse values to determine whether values 
are affected by prior experience of the relevant condition and other background 
characteristics along with severity of the state. 
 
The classification system from EORTC-8D, a recently developed preference-based 
measure for cancer derived from the EORTC QLQ-C30 is used to define the health 
states (20). The use of this classification system rather than vignettes has the 
advantage that the health state descriptions are based on the EORTC QLQ-C30, 
which is a widely used, valid and reliable measure of health related quality of life. 
Despite being developed for cancer the content of the EORTC-8D classification 
system is quite generic and makes no reference to cancer. A member of the general 
population (or anyone else) would not necessarily know it was a cancer measure. 
The classification system has no labels and hence labels can be added and removed 
without fundamentally changing the meaning of any of the dimensions. The 
classification system, shown in Table 1, has 8 dimensions: physical functioning; role 
functioning; pain; emotional functioning; social functioning; fatigue and sleep 
disturbance; nausea; constipation and diarrhoea. Each dimension has 4 or 5 severity 
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levels and the classification system defines 81,920 health states. The valuation study 
used to elicit preference weights for all states defined by the classification system 
did not include a condition label (20). 
 
Methods 
 
Given that the classification system analysed here is intended for use to capture 
quality of life changes in cancer patients, and did not include a condition label in the 
original valuation study, two of the labels chosen for this study were no label and a 
cancer label. We were further interested in testing the generalisability of this finding 
to another condition and selected one other condition that might be reasonably 
perceived by respondents to account for health states described using EORTC-8D. 
The third label chosen was irritable bowel syndrome (IBS) as several clinicians and 
doctors suggested that this is a condition that would be accurately described by the 
EORTC-8D classification system. 
 
Valuation survey 
 
A valuation study was conducted where members of the general population each 
valued the same 8 health states from EORTC-8D using time trade-off (TTO). The 
sample was divided into 3 groups: no label, IBS label and cancer label. These groups 
were interviewed in sequence, with all of the respondents from the first group being 
interviewed before respondents from the second group were contacted. This was 
undertaken in order to avoid the risk of contamination. 
 
A representative sample of the general population was used for each of the 3 groups. 
To ensure each group had the same characteristics and were a representative sample 
of the UK, the sampling strategy involved two steps. Firstly all households contacted 
to request participation in the study were sampled using the AFD Names and 
Numbers version 3.1.25 database (AFD Software Limited, Ramsey, UK) and the sample 
was then balanced to the UK population according to ACORN profiles. Secondly each 
unique postcode included in the sample was divided into 3 to form 3 separate 
samples for each group. The sample size was chosen to enable the comparison of 
mean values between health states with the inclusion of each condition label using 
simple t-tests. Assuming a power of 0.8, significance level of 
0.05, standard deviation of 0.3 and an expected difference of 0.1, this requires a 
sample of 73 valuations for each state and a total of 219 completed interviews. 
 
Eight health states were selected to represent the range of possible values for the 
measure, and this was informed by the results of the original valuation study (20). 
The original study valued 85 health states across 12 combinations of states (card 
blocs) each with 8 states, where 81 states were chosen using an orthogonal array and 
this was supplemented by 4 additional states. Selection criteria for the most 
appropriate combination of 8 health states (card bloc) to be selected from those 
valued in the original study included: minimum prediction error per card bloc, largest 
range of mean TTO distribution per card bloc, smallest missing data per card bloc, 
and general ‘feasibility’ of states (for example avoiding ‘You were not limited in 
pursuing your hobbies or other leisure time activities’ combined with ‘Your physical 
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condition or medical treatment interfered very much with your social activities’). The 
selected states are: 11111111, 31212241, 13423411, 44321321, 23141224, 24432411, 51224434, 
544444444, where 1 is no problems and level 4 is the worst level (5 for physical 
functioning dimension). An example health state (51224434) using each label is shown 
in Figure 2. 
 
At the start of the interview respondents were asked to read and self-complete the 
classification system with the relevant condition label, to familiarise themselves with 
the system. Secondly, as a warm-up task prior to TTO respondents were asked to 
rank 8 health states alongside ‘full health’ and ‘dead’. Thirdly respondents valued the 
8 states using the Measurement and Valuation of Health (MVH) study version of TTO 
including a visual prop designed by the MVH Group (University of York) (1). To 
familiarize respondents with the TTO task, respondents completed a practice TTO 
question for an additional state (22332322) prior to valuing the 8 health states. Finally 
respondents self-completed questions covering their demographic and socio- 
economic characteristics. 
 
For the two groups involving a label, the condition was mentioned in the cover letter, 
information sheet about the study, and on the cards used in the valuation exercises. 
Prior to self-completing the EORTC-8D classification system respondents in the 
labelling groups were shown an information sheet about the relevant condition 
(included in the appendix). A question on whether the respondent has experience of 
the condition, in themselves, in family or in caring for others, was included in the self- 
complete socio-demographic questions at the end of the interview. 
 
Respondents were interviewed in their own home by trained and experienced 
interviewers who had worked on previous valuation surveys, including the HUI2 (21), 
and OAB-5D (11). The project was approved by the ScHARR Research Ethics 
Committee at the University of Sheffield. 
 
Analysis 
 
Respondents are excluded from the analysis if they value all states as identical and 
less than one; value the worst possible health state higher than every other state; or 
value all states as worse than dead. Descriptive statistics of health state values across 
the three label groups are presented. Mean health state values are compared across 
the three condition labels using simple t-tests. 
 
Regression techniques are used to estimate the impact of each label on health state 
values. The regression analysis further examines whether experience of the condition 
being valued impacts on health state values, whilst controlling for other socio- 
demographic characteristics. The standard specification is: 
 
yij  = α + βx j + γqi  + θrij + δzi  + ε ij 
 
(1) 
 
where i = 1, 2, ..., n 
 
represents individual respondents and j = 1, 2, ..., m represents 
the 8 health states. The dependent variable, y, represents the TTO utility value, x 
HEDS Discussion Paper 10/09: Impact of labelling on health state values 
Rowen, Brazier, Tsuchiya, Young and Ibbotson 
8 
 
 
 
represents the vector of dummies for the health states, q represents the vector of 
dummies to capture labelling effects, r represents the vector of interaction terms to 
capture labelling and severity effects, z represents the vector of socio-demographic 
characteristics including experience with the condition, and 
ε ij
 
 
represents the error 
term. All respondents have multiple observations and random effects generalized 
least squares (GLS) models are used to take account of this (22). Goodness of fit 
statistics are reported. STATA version 9 was used for all regression analysis and 
SPSS version 15 was used for the descriptive statistical analysis. 
 
The data 
 
Two hundred and forty one respondents from the North of England were 
successfully interviewed, providing a response rate of 39% of respondents who 
answered their door to the interviewer. The completion rate across all completed 
interviews was 99% for all TTO tasks. All responses were included in the analysis as 
no respondents met the exclusion criteria. 
 
Characteristics of the overall sample are compared to the general population in South 
Yorkshire and England in Table 2. The study sample has a larger proportion of females, 
retired people and respondents aged over 65 and a lower proportion of self- 
employed and employed individuals. Mean EQ-5D score for the sample is lower than 
the general population in England (0.82 compared to 0.86 (23)). 
 
Respondent characteristics vary significantly at the 5% level across the three groups 
regarding respondents aged 18-40 and full-time students (Table 3) using a factorial 
analysis of variance (ANOVA) estimated using a generalized linear model. The IBS 
label group has a relatively smaller proportion of respondents aged 18 to 40 and full 
time students and the no label group has a relatively higher proportion of full-time 
students. The cancer label group has a larger proportion of respondents with 
experience of the condition in their family and in caring for others than the IBS 
group, but a smaller proportion of respondents with experience of the condition in 
themselves. This may reflect the prevalence of the condition, but may also reflect 
that cancer is a more obvious condition to others. 
 
Results 
 
Descriptive statistics 
 
Table 4 presents descriptive statistics of health state values across the three labelling 
groups: no label; IBS label; and cancer label. For 6 of the 8 health states the mean value 
is highest for the IBS label. For 6 of 8 states the mean value is lowest for the cancer 
label, and these are for the more severe health states. Mean, median and 
inter-quartile range for the two mildest states are similar across all 3 groups, yet 
differences are apparent for the cancer label group for more severe states and most 
noticeably for the worst (pits) state 54444444. In comparison to tariff values 
estimated in the original valuation study with no labels (20), mean health state values 
are lower for 7 of 8 states in the cancer label group, 6 of 8 states in the no label 
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group and 3 of 8 states in the IBS label group. However differences in mean health 
state value between the tariff value and values from the no label and IBS label groups 
are small, with the exception of the worst (pits) state 54444444. The proportion of 
observations that are worse than dead (below zero) varies from 5.0% in the no label 
group and 7.5% in the IBS label group to 12.7% in the cancer label group. The 
proportion of observations equal to 1 varies from 29.4% in the no label group and 
27.0% in the IBS label group to 21.2% in the cancer label group. 
 
Simple t tests reveal that health state values for the cancer label group are 
significantly different to health state values for both the no label group (P value = 
0.006) and the IBS group (P value = 0.000) but that there are no significant 
differences between the no label and IBS groups (P value =0.283). 
 
Regression analysis 
 
Table 5 presents regression analysis examining the relationship between health state 
values, health state descriptions, labels and socio-demographics. Model (1) includes 
only state level dummy variables and label dummy variables; model (2) in addition 
incorporates socio-demographic variables; model (3) in addition includes experience 
of the labelled condition, model (4) adds to model (2) interaction terms to reflect 
the interaction between the specific health state and labelled condition; and model 
(5) combines variables included in models (3) and (4). 
 
Regarding the socio-demographics and explanatory variables used in the regression 
analysis, spearman correlation coefficients indicate poor correlation (<|0.3| (24)) with 
the exception of moderate correlation (<|0.7| (24), here are <|0.5|) between 
employed and retired variables and between experience of IBS in family and in caring 
for others variables. This indicates that multicollinearity should not be a problem and 
that the use of these variables together is acceptable. Models incorporating a range 
of socio-demographic and experience variables were estimated and the best models 
(using diagnostics, correlations and proportion of significant coefficients) are 
presented here. The choice of variables was also informed using the results from 
ANOVA and related tests (not reported). 
 
The results show that all state dummy variables are significant at the 1% level and are 
consistent, meaning that the utility decrement is larger for more severe health states 
as expected (where severity is calculated by summing the levels of all dimensions). 
Across all models the IBS label is never significant and the cancer label is significant in 
models (2) and (3) but not in model (1). Statistical measures of within, between and 
overall R-squared, root mean squared error, rho and Wald chi-squared indicate that 
models (2), (3), (4) and (5) perform better than model (1). This shows that the 
inclusion of socio-demographics variables and interaction terms rather than a simple 
additive labelling variable for cancer improves the model. The inclusion of experience 
of the labelled condition also improves the model. Models were estimated with 
interaction terms for IBS but these variables were never significant and did not 
improve the model. 
HEDS Discussion Paper 10/09: Impact of labelling on health state values 
Rowen, Brazier, Tsuchiya, Young and Ibbotson 
10 
 
 
 
Interaction terms for the state and the cancer label are significant for the five more 
severe states but not for the three least severe states. There is little difference in the 
coefficients for states 44321321, 23141224, 24432411 and 51224434, varying from a 
utility decrement of -0.093 to -0.114 in model (4). However the size of the utility 
decrement for the most severe (pits) state 54444444 is much larger at -0.219 in 
model (4). The inclusion of the interaction terms reduces the size of the coefficient 
for the state dummy variables with the exception of state 31212241. For this state, the 
interaction term is positive in model (4) but not significant. Variables representing 
experience of the labelled condition are significant for the cancer label but not for the 
IBS label. Experience of cancer in themselves has a utility decrement, whereas 
experience of cancer in caring for others has a significant utility increment in both 
models where it is included. Only two socio-demographic variables are significant; 
being a student reduces all utility values and being unemployed increases all utility 
values (although note that the number of respondents in each category is small). 
 
Discussion 
 
Our results demonstrate that the inclusion of a condition label can affect health state 
values, but this is dependent upon the specific condition. This is in accordance with 
the literature where some studies find that labelling affects health state values, 
whereas other studies find the reverse. Contrary to previous studies we find that the 
inclusion of a cancer label in health state descriptions affects health state values and 
we further find that the impact is dependent upon the severity of the state. When 
label and severity interactions are accounted for in the model, the inclusion of a 
cancer label does not significantly affect health state values for milder states, but has 
a significant reduction in health state values for more severe states (from 0.093 to 
0.114 in model (4)) and a noticeably larger reduction for the worst state (0.219 in 
model (5)). 
 
The inclusion of an IBS label rather than no condition label does not significantly 
affect health state values though the values are slightly raised, and this is consistent 
across all states of differing severity. The difference in impact on values across the 
two labels is striking. One possible reason causing the impact is that the prior 
knowledge and preconception of the condition is different in each case. IBS is a long- 
term chronic disorder affecting the digestive system that is not well publicised and 
generally regarded as mild. Cancer is used to refer to many different conditions 
affecting different parts of the body, and can be terminal. It is associated with fear 
and dread, and comes with preconceived ideas about prognosis that may influence 
values. This knowledge may affect the values assigned to health states, despite the 
fact that the quality of life and health state description is identical. 
 
Another possibility is that the difference in condition represents a change in the 
underlying health state, and this is what affects values. For example, respondents may 
place a different value on interference with social activities due to, say, needing to be 
near a toilet than due to undergoing chemotherapy. This raises the question of 
whether health state values should reflect this difference. The aim of producing 
health state values is to inform resource allocation decisions across all conditions 
and patient groups, meaning there must be comparability across common health 
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state descriptions regardless of the underlying condition. Otherwise this could imply 
that, for example, a given generic EQ-5D state has a lower utility value for a patient 
with cancer than for a patient with IBS. We therefore argue that health state values 
developed for use in resource allocation should not reflect any difference in values 
introduced by referring to a medical condition. This poses difficulties for preference- 
based measures derived from existing condition-specific measures with items that 
mention the condition. Here a choice must be made between either maintaining the 
reference to the condition with the possibility of introducing a distortion in values, or 
removing the condition label meaning that the preference-based measure does not 
perfectly map to the original measure. Neither option is ideal. One alternative is to 
develop a descriptive system de novo, yet this is time consuming and expensive. 
Furthermore condition-specific preference-based measures are often developed 
from existing measures because of their wide usage and established reliability and 
validity, and sometimes because this enables utilities to be obtained from existing 
datasets where other options are unsuitable. 
 
Each label group has a large proportion of respondents with experience of the 
condition (40% in the IBS group, 78% in the cancer group) and variables 
representing experience of cancer in themselves and in caring for others were 
significant in the regression analysis. This is problematic as it again suggests that the 
elicited values may not purely reflect the health state being valued. ANOVA tests (not 
reported) revealed that IBS values were affected by experience of IBS in the family or 
in caring for others, yet these variables were insignificant in the regression analysis. 
Experience of cancer in themselves leads to lower health state values, which is 
inconsistent with the literature examining patient values where it is found that 
patients provide higher health state values than the general population (25). 
Experience of cancer in caring for others leads to higher health state values, meaning 
greater unwillingness to sacrifice years of life in return for increased quality of life. 
This could be due to a variety of reasons such as knowledge of adaptation, although 
this would be incompatible with the previous finding. 
 
Generic preference-based measures are claimed to be applicable for a wide range of 
patients and interventions, to allow comparability in economic evaluations undertaken 
across competing interventions. Yet generic measures are not always available or 
appropriate and in these circumstances condition-specific preference- based 
measures are one option that can be used to produce utility values for use in 
economic evaluation. To ensure comparability across economic evaluations health 
state values produced by different preference-based measures should reflect the 
health state description and should not be affected by the reference to the condition 
per se. We demonstrated that the condition label of cancer affected values whereas 
the IBS label did not, and hence further research is required to determine which 
condition labels may distort values. Until this information is available, it is 
recommended to avoid condition labels in health state descriptions to ensure that 
values are not distorted by prior knowledge or preconception of the condition. 
However for some conditions and existing measures this is impractical, as the 
condition label is embedded within the classification system. 
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Table 1: EORTC-8D classification system 
 
During the past week: 
 
Physical functioning 
You had no trouble taking a long walk 
You had a little trouble taking a long walk 
You had quite a bit of trouble taking a long walk 
You had very much trouble taking a long walk 
You had very much trouble taking a short walk outside of the house 
 
Role functioning 
You were not limited in pursuing your hobbies or other leisure time activities 
You were limited a little in pursuing your hobbies or other leisure time activities 
You were limited quite a bit in pursuing your hobbies or other leisure time activities 
You were limited very much in pursuing your hobbies or other leisure time activities 
 
Social functioning 
Your physical condition or medical treatment did not interfere with your social 
activities 
Your physical condition or medical treatment interfered a little with your social 
activities 
Your physical condition or medical treatment interfered quite a bit with your social 
activities 
Your physical condition or medical treatment interfered very much with your social 
activities 
 
Pain 
Pain did not interfere with your daily activities 
Pain interfered a little with your daily activities 
Pain interfered quite a bit with your daily activities 
Pain interfered very much with your daily activities 
 
Emotional functioning 
You did not feel depressed 
You felt a little depressed 
You felt quite a bit depressed 
You felt depressed very much 
 
Fatigue and sleep disturbance 
You were not tired 
You were a little tired 
You were quite a bit tired 
You were tired very much 
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Constipation and diarrhoea 
You were not constipated and did not have diarrhoea 
You were constipated and/or had diarrhoea a little 
You were constipated and/or had diarrhoea quite a bit 
You were constipated and/or had diarrhoea very much 
 
Nausea 
You did not feel nauseated 
You felt a little nauseated 
You felt nauseated quite a bit 
You felt nauseated very much 
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Table 2: Respondent characteristics 
 
Sample South England2 
  (n=241)  Yorkshire 1   
Mean age (s.d.) 49.95 (19.84) NA NA 
Age distribution 
18-40 39.8% 41.2% 41.6% 
41-65  32.8%  39.1%  39.1% 
Over 65 25.3% 19.7% 19.3% 
Female  60.2%  51.2%  51.3% 
Married/Partner 57.3% NA NA 
Employed or self-employed 38.6% 56.1% 60.9% 
Unemployed 3.7% 4.1% 3.4% 
Long-term sick 5.8% 7.7% 5.3% 
Full-time student 7.1% 7.5% 7.3% 
Retired 28.2% 14.4% 13.5% 
Own home outright or with a 
mortgage 
69.3% 64.0% 68.7% 
Renting property 30.3% 36.0% 31.3% 
Secondary school is highest level of 
education 
44.0% NA NA 
EQ-5D score (s.d.) 0.82 (0.25) NA 0.86 
  (0.23)2   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
1 
Statistics for South Yorkshire Health Authority and for England in the Census 2001. Questions used 
in this study and the census are not identical. The census includes persons aged 16 and above 
whereas this study only surveys persons aged 18 and above. Age distribution is here reported as the 
percentage of all adults aged 18 and over. 
2 
Interviews conducted in the Measurement and Valuation of Health (MVH) study in 1993 (23). 
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Table 3: Respondent characteristics by label 
 
 
No label IBS label Cancer ANOVA 
(n=81) (n=80) label P-value 
  (n=80)   
Mean age (s.d.) 48.08 
(21.57) 
51.78 
(18.93) 
47.1 (18.85) 0.300 
Age distribution 
18-40 45.6% 28.8% 46.3% 0.045 
41-65 26.6% 40.0% 32.5% 0.165 
Over 65 27.8% 27.5% 21.3% 0.316 
Female 61.7% 62.5% 56.3% 0.681 
Married/partner 63.0% 52.5% 56.3% 0.400 
Main activity 
Employed or self-employed 35.8% 38.8% 41.3% 0.779 
Unemployed 2.5% 2.5% 6.3% 0.350 
Long-term sick 7.4% 3.8% 6.3% 0.602 
Full-time student 12.3% 2.5% 6.3% 0.048 
Housework 8.6% 13.8% 15.0% 0.435 
Retired 29.6% 32.5% 22.5% 0.354 
Own home outright or with a 
mortgage 
71.3% 67.5% 70.0% 0.913 
Renting property 28.7% 32.5% 30.0% 0.851 
Secondary school is highest level of 
education 
48.1% 43.8% 40.0% 0.584 
EQ-5D score (s.d.) 0.78 
(0.30) 
0.80 (0.27) 0.85 (0.20) 0.290 
TTO completion rate 98.6% 99.4% 99.5% 
Doubtful whether respondent 
understood TTO (interviewer 
reported) 
3.8% 3.9% 1.3% 
Experience of labelled condition                                    40.0%             78.0% 
in themselves                                                                   18.8%              12.5% 
in family                                                                             27.5%             67.5% 
in caring for others                                                         13.8%              36.3% 
  Time taken  32.7 (10.3)  32.8 (9.3)  33.8 (9.5)   
  
HEDS Discussion Paper 10/09: Impact of labelling on health state values 
Rowen, Brazier, Tsuchiya, Young and Ibbotson 
 
Table 4: Descriptive statistics of health state values across all labelling groups 
 
 Original study (20) 
(n=344) 
No label (n=81) IBS label (n=79-80)1 Cancer label (n=79-80)1 
Health 
state 
Tariff value Mean Median IQR 
(s.d.) 
Mean Median IQR 
(s.d.) 
Mean Median IQR 
(s.d.) 
11111111 
 
31212241 
 
13423411 
 
44321321 
 
23141224 
 
24432411 
 
51224434 
 
54444444 
1 
 
0.75 
 
0.72 
 
0.65 
 
0.64 
 
0.64 
 
0.51 
 
0.29 
0.96 1.00 1.00 - 
(0.13)  1.00 
0.74 0.83 0.61 - 
(0.32)  1.00 
0.67 0.73 0.49 - 
(0.30)  1.00 
0.66 0.73 0.48 - 
(0.35)  1.00 
0.63 0.69 0.48 - 
(0.36)  1.00 
0.66 0.73 0.46 - 
(0.33)  1.00 
0.49 0.53 0.26 - 
(0.41)  0.84 
0.20 0.18 0.00 - 
(0.49)  0.54 
0.99 1.00 1.00 - 
(0.06)  1.00 
0.81 0.88 0.70 - 
(0.23)  1.00 
0.71 0.83 0.60 - 
(0.37)  0.93 
0.68 0.76 0.58 - 
(0.37)  0.93 
0.69 0.79 0.53 - 
(0.36)  0.98 
0.65 0.78 0.50 - 
(0.40)  0.94 
0.53 0.60 0.38 - 
(0.42)  0.83 
0.17 0.16 -0.03 - 
(0.49)  0.50 
0.96 1.00 1.00 - 
(0.12)  1.00 
0.80 0.88 0.68 - 
(0.22)  1.00 
0.64 0.78 0.46 - 
(0.36)  0.93 
0.56 0.70 0.48 - 
(0.50)  0.93 
0.57 0.68 0.48 - 
(0.45)  0.80 
0.54 0.66 0.38 - 
(0.44)  0.83 
0.41 0.50 0.23 - 
(0.49)  0.78 
-0.03 0.00 -0.38 - 
(0.50)  0.38 
1 Eighty observations for all states with the exception of states 11111111 and 13423411 for the IBS label group and states 11111111, 31212241 
and 54444444 for the cancer label group. 
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Table 5: Regression analysis of health state values across different labelling 
groups 
 
 
 (1) (2) (3) (4) (5) 
States      
31212241 -0.187*** -0.187*** -0.187*** -0.197*** -0.197*** 
13423411 - - - - - 
 0.297*** 0.297*** 0.297*** 0.284*** 0.284*** 
44321321 - - - - - 
 0.340*** 0.340*** 0.340*** 0.304*** 0.303*** 
23141224 - - - -0.313*** -0.313*** 
 0.343*** 0.343*** 0.343***   
24432411 - - - -0.317*** -0.317*** 
 0.354*** 0.354*** 0.353***   
51224434 - - - - - 
 0.489*** 0.489*** 0.489*** 0.456*** 0.456*** 
54444444 - - - - - 
 0.856*** 0.856*** 0.856*** 0.785*** 0.784*** 
 
Labelling 
IBS 0.027 0.015 -0.009 0.014 -0.009 
Cancer -0.067 -0.083** -0.115**   
 
Cancer interaction 
terms 
11111111 x Cancer -0.006 -0.038 
31212241 x Cancer 0.027 -0.005 
13423411 x Cancer -0.044 -0.076 
44321321 x Cancer -0.112** -0.145** 
23141224 x Cancer -0.093* -0.126** 
24432411 x Cancer -0.114** -0.146** 
51224434 x Cancer -0.102* -0.134** 
54444444 x Cancer -0.219*** -0.251*** 
 
Experience of labelled 
condition 
Cancer in 
themselves 
Cancer in caring for 
others 
IBS in caring for 
others 
 
 
 
-0.149 -0.150* 
 
0.142** 0.142** 
 
0.037 0.036 
IBS in family 0.072 0.073 
 
Socio-demographics 
Female 0.011 0.007 0.010 0.007 
Married 0.055 0.056 0.055 0.056 
  Retired  -0.036  -0.024  -0.036  -0.024   
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 (1) (2) (3) (4) (5) 
Unemployed 
Student 
 
Housework 
 0.119 
- 
0.244*** 
0.003 
0.135* 
-0.241*** 
 
0.008 
0.119 
- 
0.245*** 
0.002 
0.135* 
-0.241*** 
 
0.008 
Long term sick  0.063 0.098 0.063 0.098 
 
Constant 
 
0.983*** 
 
0.972*** 
 
0.966*** 
 
0.946*** 
 
0.940*** 
Observations 1910 1910 1910 1910 1910 
Number of id 241 241 241 241 241 
Within R-squared 0.453 0.453 0.453 0.462 0.462 
Between R-squared 0.028 0.115 0.149 0.115 0.149 
Overall R-squared 0.028 0.115 0.149 0.115 0.149 
Root MSE 0.271 0.271 0.272 0.270 0.270 
  Wald Chi-squared  1376.873  1397.769  1406.900    1445.517  1454.406   
Notes: *** significant at 1% level, ** significant at 5% level, * significant at 10% 
level. 
Reference state is 11111111 valued with no label. 
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Appendix: Information sheets about IBS and cancer 
 
 
 
What is irritable bowel syndrome? 
 
Irritable bowel syndrome (IBS) is a chronic (long-term) disorder that 
affects the digestive system. It causes abdominal pain, 
diarrhoea and constipation. There are different types of irritable bowel 
syndrome, depending on your main symptom. 
 
Taken from the NHS Direct website, see www.nhs.uk 
 
 
 
 
What is cancer? 
 
Cancer is a term that is used to refer to a number of conditions where the 
body's cells begin to grow and reproduce in an uncontrollable way. This 
rapid growth of cancerous cells is known as a malignant tumour. These 
cells can then invade and destroy healthy tissue, including organs. There 
are hundreds of different types of cancer. 
 
Taken from the NHS Direct website, see  www.nhs.uk 
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